Selected for AMED’s FY2025 Program for Promoting Innovative Drug Development for Emerging and Re-emerging Infectious Diseases — Healthtech Challenge
We are pleased to announce that our project has been selected for the FY2025 Healthtech Challenge, a research initiative conducted by the Japan Agency for Medical Research and Development (AMED) under the Program for Promoting Innovative Drug Development for Emerging and Re-emerging Infectious Diseases.
This study aims to advance the research and development of a diagnostic kit for predicting severe dengue infection using Mylc-SRIP technology.
We aim to steadily advance clinical validation and commercialization, while establishing a predictive technology for severe disease progression that can be applied not only to dengue fever but also to other viral infections.
We remain committed to advancing innovative medical technologies that contribute to global efforts in combating infectious diseases
